Becton dickinson and co - Search Tips: Click on the All tab to broaden your search across all BD.com content. Check the Knowledge Center for literature, case studies, events, or other documents. Explore our Products and Solutions. Search for related topics of interest using the search bar above, then try modifying your search using the filters at left.

 
Aug 3, 2023 · Operator. Hello, and welcome to BD’s Third Fiscal Quarter of 2023 Earnings Call. At the request of BD, today’s call is being recorded. And will be available for replay on BD’s Investor ... . Las vegas witamy w nevadzie

BD Announces Launch of a Mobile App in Canada to Support Reporting from the BD Veritor ™ Plus System for Rapid Antigen Testing. Learn more. Product Alerts – Medical device recalls and other notices. 1/27/23 - BD Awards Educational Grant for Point of Care Testing Pilot in Alberta.In 1897, Maxwell Becton and Fairleigh Dickinson founded Becton, Dickinson and Company with a vision to improve outcomes for patients. With more than a century of experience and our global reach, BD leads in patient and healthcare worker safety and the technologies that enable medical research and clinical laboratories. BD annual reports ... Becton, Dickinson and Company made its initial public offering on April 23, 1962, at $25 a share. An initial purchase of 100 shares on that date would have increased to more than 14,400 shares by the end of Fiscal 2015, assuming all dividends were reinvested and shares were adjusted for stock splits, which occurred on 12/26/63, 11/23/66, 3/31/69, 2/28/86, 2/26/93, 8/15/96 and 8/20/98.FRANKLIN LAKES, N.J., April 1, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has completed its spinoff of Embecta Corp. (embecta) (NASDAQ: EMBC), which holds BD's former Diabetes Care business and is now one of the largest pure-play diabetes management companies in the world.Unlock the full potential of the BD FACSymphony™ platform with the flexibility of spectral unmixing or compensation workflows. "BD Horizon RealYellow™ 586 (RY586) Reagents look like the best alternative for PE and will simplify panel design on conventional flow cytometers. They can also be an additional dye for spectral panel design.”.BD (Becton, Dickinson and Company) medical supplies, and laboratory equipment catalog features information on syringes, needles, microbiology, laboratory, diabetes, infusion, ophthalmic, surgical, medication and specimen management products.An automated medication dispensing system supporting centralized medication management. It helps clinicians safely and efficiently dispense the right medications, for the right patients at the right time. The BD Pyxis™ MedStation™ ES along with the BD Pyxis™ ES platform offers enterprise-wise medication management through integration with HIT systems. About BD Vacutainer ®. The BD Vacutainer ® product family enhances sample quality while helping protect nurses, phlebotomists and other caregivers from costly accidental needlestick injuries. The brand also helps reduce retests, recollects and instrument downtime to improve lab productivity and workflow. Unlock the full potential of the BD FACSymphony™ platform with the flexibility of spectral unmixing or compensation workflows. "BD Horizon RealYellow™ 586 (RY586) Reagents look like the best alternative for PE and will simplify panel design on conventional flow cytometers. They can also be an additional dye for spectral panel design.”.Search Tips: Click on the All tab to broaden your search across all BD.com content. Check the Knowledge Center for literature, case studies, events, or other documents. Explore our Products and Solutions. Search for related topics of interest using the search bar above, then try modifying your search using the filters at left. Sep 1, 2023 · Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (70.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (22.2%): automated systems for blood testing, mycobacteria detection ... Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment ...Jun 30, 2023 · Becton, Dickinson, and Company, together with its subsidiaries and affiliates (collectively, “BD,” “Company,” “us,” “we,” or “our”), is committed to protecting the privacy of Personal Data (i.e., information reasonably related to a specific person). Becton Dickinson Pty. Ltd., an Australian subsidiary company, commenced operations in Melbourne in 1981. In October 1996, Becton Dickinson Limited (New Zealand) was established to demonstrate the company's total commitment to servicing both the Australian and New Zealand markets. BD has a strong presence across its three core businesses in ...The BD Physioject™ Disposable Autoinjector 1 mL is a commercially proven, easy-to-use, button-activated, disposable autoinjector for the treatment of chronic diseases. 2,6,7. The BD Physioject™ Disposable Autoinjector 1 mL combined with BD Hypak™ for Biotech Glass Prefillable Syringes supports dose accuracy and enables the delivery of a ... Choose insulin syringes designed for comfortable injections, in line with the latest recommendations on insulin delivery Just as effective as insulin syringes with longer needles, our 6-mm insulin syringes, like the BD insulin syringe with the BD Ultra-Fine ™ 6mm needle, reduce anxiousness, and they are less likely to cause painful injections into the muscle. 2,3 Utilizing thin wall ...Becton Dickinson and Co (BD) is a medical technology company, which manufactures and sells medical devices, reagents, and instruments. Its major products include syringes and pen needles; intravenous catheters; infusion pumps and disposables; automated medication dispensing and supply management systems; pre-fillable drug delivery systems; respiratory ventilation and diagnostic equipment and ...8/2/23 - Saving Time Changes Lives: Recognising the importance of end-to-end diagnostics in the sepsis care pathway. 6/2/23 - BD opens new €4 million R&D centre in Dublin, will invest additional €30 million in Enniscorthy manufacturing plant. Events.About BD Vacutainer ®. The BD Vacutainer ® product family enhances sample quality while helping protect nurses, phlebotomists and other caregivers from costly accidental needlestick injuries. The brand also helps reduce retests, recollects and instrument downtime to improve lab productivity and workflow. Careers. BD is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. We lead in patient and healthcare worker safety, and technologies that enable medical research and clinical laboratories. Our innovative solutions help advance medical research and ... Becton Dickinson Pty. Ltd., an Australian subsidiary company, commenced operations in Melbourne in 1981. In October 1996, Becton Dickinson Limited (New Zealand) was established to demonstrate the company's total commitment to servicing both the Australian and New Zealand markets. BD has a strong presence across its three core businesses in ... 8/2/23 - Saving Time Changes Lives: Recognising the importance of end-to-end diagnostics in the sepsis care pathway. 6/2/23 - BD opens new €4 million R&D centre in Dublin, will invest additional €30 million in Enniscorthy manufacturing plant. Events.Nov 15, 2019 · Becton, Dickinson and Company (BD) of Franklin Lakes, New Jersey, protests the terms of request for quotations (RFQ) No. 36C24C19Q0037, issued by the Department of Veterans Affairs (VA), to establish blanket purchase agreements (BPAs) for the procurement of medical supplies. The protester alleges that the solicitation improperly applies the Buy ... Welcome to the world of BD. is our purpose. BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD helps customers enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. Tom Polen is the chairman, CEO and president of BD (Becton, Dickinson and Company). Polen leads the $20 billion global medical technology company headquartered in Franklin Lakes, NJ, and works alongside 75,000+ BD associates who are making an impact and fulfilling the company’s purpose of advancing the world of health™.BD Announces Launch of a Mobile App in Canada to Support Reporting from the BD Veritor ™ Plus System for Rapid Antigen Testing. Learn more. Product Alerts – Medical device recalls and other notices. 1/27/23 - BD Awards Educational Grant for Point of Care Testing Pilot in Alberta.SEC Filings/Section 16 Alerts. Press Releases Alerts. Annual Report Alerts. Annual Reports/Proxy Alerts. Questions for the Investor Relations department can be addressed to: 1-800-284-6845. [email protected]. Jun 30, 2023 · Becton, Dickinson, and Company, together with its subsidiaries and affiliates (collectively, “BD,” “Company,” “us,” “we,” or “our”), is committed to protecting the privacy of Personal Data (i.e., information reasonably related to a specific person). Your Partner in Venous Care. Venous disease impacts millions of people all around the world. BD’s venous portfolio consists of category-leading products, innovative solutions and dedicated patient resources – all designed to help improve clinical efficiency and enhance patient care. Becton, Dickinson & Co. is a medical technology company. The firm engages in the development, manufacture and sale of medical supplies, devices, laboratory equipment and diagnostic products used ...About us. BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The...BD Announces Launch of a Mobile App in Canada to Support Reporting from the BD Veritor ™ Plus System for Rapid Antigen Testing. Learn more. Product Alerts – Medical device recalls and other notices. 1/27/23 - BD Awards Educational Grant for Point of Care Testing Pilot in Alberta. Becton Dickinson India Private Limited (“BD”) does not run any investment schemes or solicit monies from general public. We have neither authorized any individual or legal entity to either collect money or arrive at any monetary arrangement for or on behalf of BD. BD is not in any way connected to the actions of any such persons.Search for BD products by name, type or SKU number. Our Solutions. BD serves and supports our customers with full offerings beyond our individual products, enabling integrated solutions across healthcare systems to comprehensively improve care and lower costs. Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (70.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (22.2%): automated systems for blood testing, mycobacteria detection ...When was Becton, Dickinson and Company's most recent ex-dividend date? Becton, Dickinson and Company's most recent ex-dividend date was Thursday, June 8, 2023. Is Becton, Dickinson and Company's dividend growing? Over the past three years, the company's dividend has grown by an average of 4.33% per year.BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD helps customers enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. BD Announces Launch of a Mobile App in Canada to Support Reporting from the BD Veritor ™ Plus System for Rapid Antigen Testing. Learn more. Product Alerts – Medical device recalls and other notices. 1/27/23 - BD Awards Educational Grant for Point of Care Testing Pilot in Alberta. Annual Reports/Proxy Alerts. Questions for the Investor Relations department can be addressed to: 1-800-284-6845. [email protected]. BD. Attn: Investor Relations. 1 Becton Drive. Franklin Lakes, NJ 07417.milestone for our company and a true testament to our history of innovation and leadership in healthcare. Our company was founded in 1897 when Maxwell Becton and Fairleigh Dickinson met by chance in a train station restaurant in Texas. Together, they forged a company with a strong set of values and a relentless focus on theTom Polen is the chairman, CEO and president of BD (Becton, Dickinson and Company). Polen leads the $20 billion global medical technology company headquartered in Franklin Lakes, NJ, and works alongside 75,000+ BD associates who are making an impact and fulfilling the company’s purpose of advancing the world of health™.Tom Polen is the chairman, CEO and president of BD (Becton, Dickinson and Company). Polen leads the $20 billion global medical technology company headquartered in Franklin Lakes, NJ, and works alongside 75,000+ BD associates who are making an impact and fulfilling the company’s purpose of advancing the world of health™.May 25, 2011 · The district court granted summary judgment of noninfringement of all asserted claims in the 164 and 745 patents. Therasense, Inc. v. Becton, Dickinson Co., 560 F.Supp.2d 835, 854, 880 (N.D.Cal. 2008). The district court also found nearly all of the asserted claims of the 745 patent invalid due to anticipation. Jul 24, 2023 · Annual Reports/Proxy Alerts. Questions for the Investor Relations department can be addressed to: 1-800-284-6845. [email protected]. BD. Attn: Investor Relations. 1 Becton Drive. Franklin Lakes, NJ 07417. Approach. Mergers and acquisitions (M&A) serve as an integral tool for BD in advancing its strategy of improving patient outcomes, reducing the cost of care, expanding access and enhancing the operations of our customers around the world. In recent years BD has completed dozens of tuck-in acquisitions including TVA Medical, Medafor, and Kiestra ... Sep 7, 2023 · BD Pyxis™ IV Prep. Intercept errors, reduce waste and optimize IV workflows BD Pyxis™ IV Prep is a comprehensive, gravimetric-based IV workflow management system that helps deliver safe and efficient medication compounding. BD Pyxis™ MedBank™. MedBank solutions focus on automating medication inventory management processes to help ... Welcome to the electronic Instructions for Use (eIFU) website. From this site you can view and print eIFUs and Patient Information Leaflets (PILs) for many BD products. Consult the current Instructions for Use or Patient Information Leaflet approved for your specific country. BD products availability are subject to local country regulatory and ...Becton, Dickinson and Company made its initial public offering on April 23, 1962, at $25 a share. An initial purchase of 100 shares on that date would have increased to more than 14,400 shares by the end of Fiscal 2015, assuming all dividends were reinvested and shares were adjusted for stock splits, which occurred on 12/26/63, 11/23/66, 3/31/69, 2/28/86, 2/26/93, 8/15/96 and 8/20/98. Jul 5, 2022 · FRANKLIN LAKES, N.J., July 5, 2022 /PRNewswire/ -- BD ( Becton, Dickinson and Company) (NYSE: BDX ), a leading global medical technology company, today issued its Fiscal Year 2021 Environmental, Social and Governance ( ESG) Report that details ongoing efforts that impact company health, human health, community health and planet health. "We are ... View the latest Becton Dickinson & Co. (BDX) stock price, news, historical charts, analyst ratings and financial information from WSJ. milestone for our company and a true testament to our history of innovation and leadership in healthcare. Our company was founded in 1897 when Maxwell Becton and Fairleigh Dickinson met by chance in a train station restaurant in Texas. Together, they forged a company with a strong set of values and a relentless focus on theGet the latest Becton Dickinson and Co (BDX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Becton, Dickinson & Co. is a medical technology company. The firm engages in the development, manufacture and sale of medical supplies, devices, laboratory equipment and diagnostic products used ...Becton, Dickinson & Co. is a medical technology company. The firm engages in the development, manufacture and sale of medical supplies, devices, laboratory equipment and diagnostic products used ... Inclusion, Diversity & Equity. Our leadership is committed to making BD the best possible place for talented people to work by driving inclusion and diversity as a cultural and strategic imperative across the company. Our associates come from all backgrounds, races, ages, colors, creeds, religions, genders, and orientations, and we are better ...1 day ago · See the latest Becton Dickinson & Co stock price (NYSE:BDX), related news, ... Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles ... View the latest Becton Dickinson & Co. (BDX) stock price, news, historical charts, analyst ratings and financial information from WSJ.View the latest Becton Dickinson & Co. (BDX) stock price, news, historical charts, analyst ratings and financial information from WSJ. Becton, Dickinson and Company | 1,076 followers on LinkedIn. BD is the world's largest manufacturer and seller of medical equipment. | BD is one of the world's largest medical technology companies ... Apple Inc. Common Stock. $180.07 -0.12 -0.07%. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs ... Business Description. Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units.* The BD Veritor™ System for Rapid Detection of SARS-CoV-2 is intended for the qualitative detection of SARS-CoV-2 nucleocapsid antigens in direct anterior nasal swabs from individuals who are either suspected of COVID-19 by their health care provider within the first five days of the onset of symptoms, or from individuals without symptoms or other epidemiological reasons to suspect COVID-19 ...BD Announces Launch of a Mobile App in Canada to Support Reporting from the BD Veritor ™ Plus System for Rapid Antigen Testing. Learn more. Product Alerts – Medical device recalls and other notices. 1/27/23 - BD Awards Educational Grant for Point of Care Testing Pilot in Alberta.When was Becton, Dickinson and Company's most recent ex-dividend date? Becton, Dickinson and Company's most recent ex-dividend date was Thursday, June 8, 2023. Is Becton, Dickinson and Company's dividend growing? Over the past three years, the company's dividend has grown by an average of 4.33% per year.Oct 4, 2010 · See Becton, Dickinson Co. v. Tyco Healthcare Group, LP, No. 02-1694 GMS, 2008 WL 4610220 at *4, 2008 U.S. Dist. LEXIS 82915 at *10 (D.Del. Oct. 14, 2008) (footnote omitted) (" JMOL Decision "). Tyco then appealed to this court, challenging the district court's interpretation of the asserted claims and the denial of its motions for JMOL and a ... Jun 30, 2023 · Becton, Dickinson, and Company, together with its subsidiaries and affiliates (collectively, “BD,” “Company,” “us,” “we,” or “our”), is committed to protecting the privacy of Personal Data (i.e., information reasonably related to a specific person). About us. BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The...Welcome to the BD Cybersecurity Trust Center. In healthcare, cybersecurity includes more than protecting systems and data. It also includes protecting patient safety and privacy. Upholding strong cybersecurity measures and continuing to advance cybersecurity is part of our commitment to customer trust. BD works diligently to help protect the ... WavelinQ™ EndoAVF System is designed to create an endovascular AV fistula (endoAVF) for hemodialysis access in patients who have chronic kidney disease and need dialysis, using a completely endovascular approach in vessels that are not traditionally used during open surgery. Patients must meet certain anatomical characteristics that support ...概要. 1897年、Maxwell BectonとFairleigh S. Dickinsonによって設立された。. アメリカ合衆国ニュージャージー州フランクリンレイクスに統合本社を置く。. 2013年現在、世界50カ国以上に支社をもち [1] 、およそ30,000人の従業員を抱える。. 事業の対象となる顧客は ...Company News. BD solutions to combat antimicrobial resistance ... Unless otherwise noted, BD, the BD Logo and all other trademarks are property of Becton, Dickinson ... About us. BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The... Becton Dickinson India Private Limited (“BD”) does not run any investment schemes or solicit monies from general public. We have neither authorized any individual or legal entity to either collect money or arrive at any monetary arrangement for or on behalf of BD. BD is not in any way connected to the actions of any such persons.In 1897, Maxwell Becton and Fairleigh Dickinson founded Becton, Dickinson and Company with a vision to improve outcomes for patients. With more than a century of experience and our global reach, BD leads in patient and healthcare worker safety and the technologies that enable medical research and clinical laboratories. BD annual reports ... When was Becton, Dickinson and Company's most recent ex-dividend date? Becton, Dickinson and Company's most recent ex-dividend date was Thursday, June 8, 2023. Is Becton, Dickinson and Company's dividend growing? Over the past three years, the company's dividend has grown by an average of 4.33% per year.BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the following healthcare conferences: 2023 Wells Fargo... 8/2/23 - Saving Time Changes Lives: Recognising the importance of end-to-end diagnostics in the sepsis care pathway. 6/2/23 - BD opens new €4 million R&D centre in Dublin, will invest additional €30 million in Enniscorthy manufacturing plant. Events.We may use Personal Data for the following purposes: A. To provide you or your company with products and services, such as providing and delivering you the goods and services you request; providing customer service; processing or fulfilling orders and transactions and fulfilling our contracts; verifying customer information; processing payments; communicating with you about your product ...Welcome to the electronic Instructions for Use (eIFU) website. From this site you can view and print eIFUs and Patient Information Leaflets (PILs) for many BD products. Consult the current Instructions for Use or Patient Information Leaflet approved for your specific country. BD products availability are subject to local country regulatory and ... The BD Physioject™ Disposable Autoinjector 1 mL is a commercially proven, easy-to-use, button-activated, disposable autoinjector for the treatment of chronic diseases. 2,6,7. The BD Physioject™ Disposable Autoinjector 1 mL combined with BD Hypak™ for Biotech Glass Prefillable Syringes supports dose accuracy and enables the delivery of a ... SEC Filings/Section 16 Alerts. Press Releases Alerts. Annual Report Alerts. Annual Reports/Proxy Alerts. Questions for the Investor Relations department can be addressed to: 1-800-284-6845. [email protected]. BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD helps customers enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. PR Newswire. FRANKLIN LAKES, N.J., Dec. 29, 2017 / PRNewswire / -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has completed the acquisition of C. R. Bard, Inc. (NYSE: BCR), creating a new health care industry leader with approximately $16 billion in annualized revenue. The ...Sep 1, 2023 · Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (70.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (22.2%): automated systems for blood testing, mycobacteria detection ... Get the latest Becton Dickinson and Co (BDX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Products. Catalog. COVID – 19 — For BD updates and statements on our efforts against the Coronavirus. BD (Becton, Dickinson and Company) medical supplies, and laboratory equipment catalog features information on syringes, needles, microbiology, laboratory, diabetes, infusion, ophthalmic, surgical, medication and specimen management products.In 1897, Maxwell Becton and Fairleigh Dickinson founded Becton, Dickinson and Company with a vision to improve outcomes for patients. With more than a century of experience and our global reach, BD leads in patient and healthcare worker safety and the technologies that enable medical research and clinical laboratories. 2030 Sustainability Goals.

When was Becton, Dickinson and Company's most recent ex-dividend date? Becton, Dickinson and Company's most recent ex-dividend date was Thursday, June 8, 2023. Is Becton, Dickinson and Company's dividend growing? Over the past three years, the company's dividend has grown by an average of 4.33% per year.. Capital auto auction philadelphia reviews

becton dickinson and co

The BD Neopak™ platform has been developed with a goal to assure the most efficient combination of product development and commercialization. the BD Neopak™ syringe is available in both 1-ml and 2.25 ml formats, and can be expanded to include BD Advanced Technologies such as BD XSi™, and BD VisioGuard™.Press Releases Alerts. Annual Report Alerts. Annual Reports/Proxy Alerts. Questions for the Investor Relations department can be addressed to: 1-800-284-6845. [email protected]. BD. Attn: Investor Relations. 1 Becton Drive.Becton, Dickinson and Company Sparks, Maryland 21152 USA iv Difco Manual Preface.ind 4 3/16/09 3:02:36 PM. 110 Section III C CDC Anaerobe 5% Sheep Blood Agar The BD Neopak™ platform has been developed with a goal to assure the most efficient combination of product development and commercialization. the BD Neopak™ syringe is available in both 1-ml and 2.25 ml formats, and can be expanded to include BD Advanced Technologies such as BD XSi™, and BD VisioGuard™.In 1897, Maxwell Becton and Fairleigh Dickinson founded Becton, Dickinson and Company with a vision to improve outcomes for patients. With more than a century of experience and our global reach, BD leads in patient and healthcare worker safety and the technologies that enable medical research and clinical laboratories. 2030 Sustainability Goals.SEC Filings/Section 16 Alerts. Press Releases Alerts. Annual Report Alerts. Annual Reports/Proxy Alerts. Questions for the Investor Relations department can be addressed to: 1-800-284-6845. [email protected] the full potential of the BD FACSymphony™ platform with the flexibility of spectral unmixing or compensation workflows. "BD Horizon RealYellow™ 586 (RY586) Reagents look like the best alternative for PE and will simplify panel design on conventional flow cytometers. They can also be an additional dye for spectral panel design.”.1 day ago · See the latest Becton Dickinson & Co stock price (NYSE:BDX), related news, ... Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles ... Franklin Lakes, NJ: Becton, Dickinson and Company; 2016. 2. Wong R, Levi AW, Harigopal M, Schofield K, Chhieng DC. The positive impact of simultaneous implementation of the BD FocalPoint GS Imaging System and lean principles on the operation of gynecologic cytology. Arch Pathol Lab Med. 2012;136 (2):183-189.SEC Filings/Section 16 Alerts. Press Releases Alerts. Annual Report Alerts. Annual Reports/Proxy Alerts. Questions for the Investor Relations department can be addressed to: 1-800-284-6845. [email protected]. .

Popular Topics